Coronado Biosciences Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Coronado Biosciences Inc (CNDO) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Coronado Biosciences Inc's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Coronado Biosciences Inc | Yes | Yes | Yes | - |
| Similar Growth & Profitability (8) | 12.50 % (1 of 8) | 87.50 % (7 of 8) | 75.00 % (6 of 8) | 16.70 % (1 of 6) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
